Standard BioTools Inc. Common Stock (LAB) is a publicly traded Healthcare sector company. As of October 1, 2026, LAB trades at $0.73 with a market cap of $290.74M and a P/E ratio of -3.62. LAB moved -1.13% today. Year to date, LAB is -42.65%; over the trailing twelve months it is -43.10%. Its 52-week range spans $0.63 to $1.72. Rallies surfaces LAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $0.73 |
| Market Cap | $290.74M |
| P/E Ratio | -3.62 |
| EPS | $-0.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.72 |
| 52-Week Low | $0.63 |
| Volume | 1.04M |
| Avg Volume | 0 |
| Revenue (TTM) | $85.33M |
| Net Income | $-74.90M |
| Gross Margin | 49.86% |
LAB analyst coverage data. Average price target: $0.00.